Recruiting OBSERVATIONAL NCT07336394
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
Multimodality Imaging (Cardiovascular Magnetic Resonance Imaging, Echocardiography, and Nuclear Medicine Imaging) in the Screening, Diagnosis and Risk Stratification of Rare Cardiomyopathies - a Multicenter Study
Sponsor: Beijing Anzhen Hospital
Conditions
Cardiac Amyloidosis Cardiac Sarcoidosis Danon Disease Fabry Disease Glycogen Storage Disease Idiopathic Cardiomyopathy Noonan Syndrome
Updated 1 time since 2026 Last updated: Jan 19, 2026 Started: Jan 1, 2010 Primary completion: Dec 30, 2028 Completion: Dec 30, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07336394, this observational or N/A phase trial focuses on Cardiac Amyloidosis and Cardiac Sarcoidosis and remains actively recruiting participants. Sponsored by Beijing Anzhen Hospital, it has been updated 1 time since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beijing Anzhen Hospital
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Peking Union Medical College Hospital
- The First Affiliated Hospital with Nanjing Medical University
Data source: Chinese Academy of Medical Sciences, Fuwai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .